PKCδ regulates hepatic insulin sensitivity and hepatosteatosis in mice and humans
Olivier Bézy(Joslin Diabetes Center), C. Ronald Kahn(Joslin Diabetes Center), Marcelo A. Mori(Universidade Estadual de Campinas (UNICAMP)), Thien T. Tran(Joslin Diabetes Center), Allison B. Goldfine(Novartis (Switzerland)), Sudha B. Biddinger(Boston Children's Hospital), Mary‐Elizabeth Patti(Joslin Diabetes Center), Joel T. Haas(Gladstone Institutes), Jussi Pihlajamäki(University of Eastern Finland), Brice Emanuelli(University of Copenhagen), Ryo Suzuki(Tokyo Medical University), George L. King(Joslin Diabetes Center), Michael Leitges(Memorial University of Newfoundland), Jonathan Winnay(Joslin Diabetes Center)
Cited by 145
Related Papers
Vascular Endothelial Growth Factor in Ocular Fluid of Patients with Diabetic Retinopathy and Other Retinal Disorders
|New England Journal of Medicine|1994|3.8k
Insulin Receptor Signaling in Normal and Insulin-Resistant States
|Cold Spring Harbor Perspectives in Biology|2014|1.4k
Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins.
|Proceedings of the National Academy of Sciences|1995|1.3k